Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells

Published:2020-04 Issue:4 Volume:10 Page:615-627
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Zhang Baoyuan,Lyu Junfang,Yang Eun Ju,Liu Yifan,Wu Changjie,Pardeshi Lakhansing,Tan Kaeling,Chen Qiang,Xu Xiaoling,Deng Chu-Xia,Shim Joong Sup

Funder

University of Macau, China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference56 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. A pathway-based classification of human breast cancer;Gatza;Proc Natl Acad Sci U S A,2010

3. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2017

4. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer;Young;BMC Cancer,2009

5. Roles of BRCA1 in DNA damage repair: a link between development and cancer;Deng;Hum Mol Genet,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer;Acta Pharmaceutica Sinica B;2024-09

2. Nobiletin regulates the proliferation and migration of ovarian cancer A2780 cells via DPP4 and TXNIP;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-05

3. Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases;Redox Biology;2024-04

4. Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells;Journal of Neuro-Oncology;2023-09

5. Depletion of pyruvate kinase (PK) activity causes glycolytic intermediate imbalances and reveals a PK-TXNIP regulatory axis;Molecular Metabolism;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3